Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...
The cumulative incidence of CRLM has declined, with survival gains mainly in synchronous cases, highlighting the need for ...
Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the ...
With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...
Researchers at Weill Cornell Medicine with an international team have used liver biopsies to identify cellular and molecular markers that can potentially be used to predict whether and when pancreatic ...
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to ...
Credit: Getty Images Investigators explore the biomarker potential of circulating tumor DNA and tumor suppressor gene status. Elevated circulating tumor DNA fraction and tumor suppressor gene loss are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback